[1]
N. S. Basappa, “Treatment options in advanced renal cell carcinoma after first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors”, CUAJ, vol. 10, no. 11-12, pp. S242–4, Dec. 2016.